Difluoromethylornithine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Difluoromethylornithine, covering 2026-01-14 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas [Phase 1, Phase 2]